Efficacy of conventional whole-body 18F-FDG PET/CT in the incidental findings of parotid masses

Annals of Nuclear Medicine

Volumn 24, Issue 8, 2010, Pages 571-577

  Wang, Hui Chun ^a   Zuo, Chuan Tao ^a   Hua, Feng Chun ^a   Huang, Zhe Min ^a   Tan, Hai Bo ^a   Zhao, Jun ^a   Guan, Yi Hui ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

FDG; Incidental findings; Parotid masses; PET CT; SUVmax

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACINAR CELL CARCINOMA; ADULT; AGED; ANGIOSARCOMA; ARTICLE; BIOPSY; CONTRAST ENHANCEMENT; DRUG TRANSPORT; DRUG UPTAKE; EPITHELIUM TUMOR; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; HEALTH CENTER; HUMAN; INFLAMMATION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVARY CANCER; PANCREAS CANCER; PAROTID GLAND DISEASE; PAROTID GLAND TUMOR; PLEOMORPHIC ADENOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; WARTHIN TUMOR; WHOLE BODY IMAGING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PAROTID NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 78149411055     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0394-6     Document Type: Article

References (21)

1. YYP Lee KT Wong AD King AT Ahuja 2008 Imaging of salivary gland tumours Eur J Radiol 66 419 436 1:STN:280:DC%2BD1czmvVejsw%3D%3D 10.1016/j.ejrad.2008. 01.027 18337041
2. Mehta A, Bansal SC. Diagnosis and management of cancer. Jaypee Brothers Medical Publishers (P) Ltd.; 2004. p. 232-52.
3. CC Lin MH Tsai CC Huang CH Hua HC Tseng ST Huang 2008 Parotid tumors: a 10-year experience Am J Otolaryngol 29 94 100 10.1016/j.amjoto.2007.03.002 18314019
4. AN Burgess GW Serpell 2008 Parotidectomy: preoperative investigations and outcomes in a single surgeon practice ANZ J Surg 78 791 793 10.1111/j.1445-2197.2008.04651.x 18844910
5. K Subhashraj 2008 Salivary gland tumors: a single institution experience in India Br J Oral Maxillofac Surg 46 635 638 10.1016/j.bjoms.2008.03.020 18620785
6. E Even-Sapir H Lerman M Gutman G Lievshitz L Zuriel A Polliack, et al. 2006 The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT Eur J Nucl Med Mol Imaging 33 541 552 10.1007/s00259-005-0056-4 16491423
7. T Ishimori PV Patel RL Wahl 2005 Detection of unexpected additional primary malignancies with PET/CT J Nucl Med 46 752 757 15872346
8. M Adriaensen L Schijf M Haas J Huijbregts HJ Baarslag G Staaks, et al. 2008 Six synchronous primary neoplasms detected by FDG-PET/CT Eur J Nucl Med Mol Imaging 35 1931 10.1007/s00259-008-0821-2 18682942
9. JY Choi KS Lee OJ Kwon YM Shim CH Baek K Park, et al. 2005 Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging J Clin Oncol 23 7654 7659 10.1200/JCO.2005.01.4340 16234527
10. W De Wever Y Vankan S Stroobants J Verschakelen 2007 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Eur Respir J 29 995 1002 10.1183/09031936.00119106 17331966
11. BF Branstetter TM Blodgett LA Zimmer CH Synderman JT Johnson S Raman, et al. 2005 Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 235 580 586 10.1148/radiol.2352040134 15858097
12. R Bar-Shalom N Yefremov L Guralnik D Gaitini A Frenkei A Kuten, et al. 2003 Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 1200 1209 12902408
13. Y Uchida S Minoshima T Kawata K Motoori K Nakano T Kazama, et al. 2005 Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors Clin Nucl Med 30 170 176 10.1097/00003072-200503000-00005 15722820
14. T Okamura J Kawabe K Koyama H Ochi R Yamada H Sakamoto, et al. 1998 Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions Acta Otolaryngol Suppl 538 209 213 1:STN:280:DyaK1M%2FpsFCqtA%3D%3D 10.1080/00016489850182954 9879423
15. S Basu M Houseni A Alavi 2008 Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management Nucl Med Commun 29 367 373 1:CAS:528:DC%2BD1cXislSlsLY%3D 10.1097/MNM.0b013e3282f8147a 18317302
16. D Rumboldt L Gordon R Bonsall S Ackermann 2006 Imaging in head and neck cancer Curr Treat Options Oncol 7 23 34 10.1007/s11864-006-0029-2 16343366
17. JW Keyes BA Harkness KM Greven DW Williams NE Watson W Frederick-McGuirt 1994 Salivary gland tumors: pretherapy evaluation with PET Radiology 192 99 102 8208973
18. 18F-FDG PET Am J Roentgenol 189 W212 W214 10.2214/AJR.05.1213
19. D Rubello C Nanni P Castellucci L Rampin M Farsad R Franchi, et al. 2005 Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses Panminerva Med 47 187 189 1:STN:280:DC%2BD28%2Fns12isg%3D%3D 16462726
20. N Ozawa T Okamura K Koyama K Nakayama J Kawabe S Shiomi, et al. 2006 Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses Radiat Med 24 41 49 10.1007/BF02489988 16715661
21. CY Lim HC Chang KH Nam WY Chung CS Park 2008 Preoperative prediction of the location of parotid gland tumors using anatomical landmarks World J Surg 32 2200 2203 10.1007/s00268-008-9663-0 18581165